Navigation Links
Oncology Drug Pemnat Launched By NATCO

Natco Pharma Ltd, based in Hyderabad, India, has announced the launch of a generic version of Pemetrexed a drug used to treat certain types of lung cancer. A very costly// preparation, Pemnat is priced at Rs 25,500 a vial. However the imported version of the same medication, costs a whopping Rs 79,000.

This marks the launch of the first ever generic version of Pemetrexed, in the global arena. The drug Pemetrexed was formulated before 1995.The Company is quite sure that this new generic version will not get entangled in any litigation issues whatsoever.

The company, in a news release, has informed that, Pemnat will be invaluable to lung cancer patients in whom curative surgery may not help. It ca be used to treat non-small cell lung cancer and certain types of malignant pleural mesothelioma (cancer affecting lining of lungs).The medicine, is available in 20 ml vials in the market for a single injection. It should be administered after chemotherapy, said the company.
MST
'"/>




Page: 1

Related medicine news :

1. Radiation Overdose at the Beatson Oncology Centre
2. Videoconferencing, an impetus to Pediatric Oncology
3. United Biotech Launches New Oncology Division
4. Nutrient Profiling System Launched By Food Officials in UK
5. New Oat And Soy-Based Fat Replacer Launched
6. Race Based Genome Project Launched By Mexico
7. Action Plan Against Drug Deaths Launched
8. New Fund Launched To Help HIV Positive Women
9. Use Of Viread Spreads As New Anti-AIDS Site Is Launched
10. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
11. Unique Smoking Helpline Launched In Manchester

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Oncology Drug Pemnat Launched NATCO

(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCall/ -...ced that Blair Lambert, CFO/COO, will present at t... held at the May Fair Hotel in London, England, on..., To listen to a live broadcast of The Gymboree...ase log on to www.gymboree.com, click on "Our Comp...
(Date:11/27/2009)...and cycling plus low-emission vehicles may reduce ..., FRIDAY, Nov. 27 (HealthDay News) -- Encouraging...g cars would offer much greater public health bene... U.K. researchers have found. , The study compa...ative urban land transport scenarios for London, E...
(Date:11/27/2009)... Specialist manufacturers who use... are saving millions of dollars by bringing in tec...s. Increasing numbers of pro-active medical manufa...t the concept stage of their projects, ensuring th...sign processes or potentially outdated technology....
(Date:11/26/2009)...pper sequestering drug tetrathiomolybdate (TM) has...tment of Wilson disease, a disease caused by an ov...That much is known. Very little, however, is known..., A new study led by Northwestern University res...three-dimensional structure of TM bound to copper-...
(Date:11/26/2009)... Research Triangle Dental (RTDent...rth Carolina, today announced the expansion of its...NEER Dentist, Dr. Doug Macmillan. , ...gle Dental is pleased to announce that Dr. Doug Ma...tly completed an additional advanced training semi...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...will be mated with the world's second dog clone, i...normally. // Snuppy, an Afghan hound who was ...ess, will be mated later this year with second-in-...Both Snuppy and Bona are healthy. The mating is ai...
...n who drink more two bottles of wine over the week...ast cancer. // The study reported in the Europ...p of 17,647 nurses who drank 22-27 drinks a week c...r a short time. The study, which began in 1993, sh...
...stration (FDA) today approved the first generic ve...ease tablets.// Zolpidem (ZOLE-pi-dem) tartrate is...term treatment of insomnia. "The FDA’s Offi...aid Gary J. Buehler, director, Office of Generic D...
...have to pay heavily for the salmonella scare that ...inform the concerned authority about the possible ... samples of chocolates at their factory. They had ...e Birmingham City Council in the UK announced its ...
...nized to thrash out issues pertaining to indigenou... focus attention on a burning issue - high rate of...he Inuit population of Nunavik, Canada, the suicid...k of attention on child issues. Most of the hospit...
... all that bad for you. Recent research has confirm...duced chances of developing childhood asthma.// ... of Medicine, who published their report in the jo... history. This involved about 8000 adults. Th...
Other Medicine News:Health News:Women Binge- Drinkers Warned Of Possible Link To Breast Cancer 2Health News:FDA Approves First Generic Versions of Ambien for Insomnia 2Health News:Cadbury Indicted on Salmonella Scare 2Health News:Suicide - Aboriginal Communities Take Stock of the Killing Numbers 2Health News:Ulcer Causing Microbe Linked To Protection From Asthma 2
(Date:11/25/2009)...RNewswire-FirstCall/ -- Heska Corporation ( HSKA);...ostic and specialty products to the veterinary ind...ostics Corporation for the supply of blood gas pro...y market. ,, (Logo: http://www.newscom.com...d Roche share the same passion for innovating in t...
(Date:11/25/2009)...ewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: V...mitted to discovering, developing and commercializ...d financial results for the fiscal year ended Sept...eld $58.4 million in cash, cash equivalents and sh...2009 Highlights ,, RG7128 ,, Phase 2b T...
(Date:11/25/2009)..., Nov. 25 From November 16-18, Ph...ng solutions, presented the second edition of the ...e special needs of the older population. The confe...d audiology from around the world and more than 25...ith hearing loss for an opportunity to share exper...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3MDC researchers discover molecule responsible for axonal branching 9993 1MDC researchers discover molecule responsible for axonal branching 9993 2Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions 57770 1Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions 57770 2Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions 57770 3Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions 57770 4Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions 57770 5Lilly Receives 100 Percent Rating on Corporate Equality Index Survey 57767 1Lilly Receives 100 Percent Rating on Corporate Equality Index Survey 57767 2
...advanced leukemia and myelodysplastic, syndrome p...gy meeting., PRINCETON, N.J., Dec. 10 Celator Ph...ing Phase I study of CPX-351, a liposomal,formulat...abine and,daunorubicin for the treatment of advanc...dose escalation in the study is ongoing, thus far ...
... and,Drug Administration (FDA) today issued its fi...cal studies in patients with gastro-esophageal ref...with either omeprazole,(SOPRAN study) or NEXIUM(R)...N ) agrees with the FDA conclusion which states,"F...se drugs is not likely,to be associated with an in...
Other Medicine Technology:Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: